ArticleDiabetology & metabolic syndrome2025
Association of the interaction between interleukin-1β gene polymorphism and smoking status with the diabetic nephropathy risk in a Chinese Han population.
Article in Diabetology & metabolic syndrome, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveswe aimed to evaluate the association of interleukin-1β (IL-1β) gene single nucleotide polymorphisms (SNPs) and its interaction with smoking status on diabetic nephropathy (DN) risk in a Chinese Han population.
methodsThe Hardy-Weinberg equilibrium (HWE) was tested by using SNPStats ( https://www.snpstats.net/start.htm ), which was also used for testing the relationship between four SNPs and DN risk and haplotype analysis. The SNP- SNP and gene- smoking interaction were verified by using generalized multifactor dimensionality reduction (GMDR) model.
resultsLogistic regression suggested that the DN risks of participants with rs16944- G allele were significantly higher than those with AA genotype, adjusted OR (95%CI) = 1.62 (1.24-2.01) for AG versus AA, 1.41 (0.75-2.12) for GG versus AA. Additionally, we also found that participants with rs3917356- T allele had an obviously higher DN risk than those with CC genotype, adjusted OR (95%CI) = 1.75 (1.34-2.19) for CT versus CC, 1.87 (1.23-2.54) for TT versus CC. GMDR model found a significant two-locus model (P = 0.011) including rs16944 and smoking. Compared with non- smokers with rs16944- AA genotype, smokers with rs1225404 AG or GG genotype had the highest DN risk after covariates adjustment, OR (95%CI) was 3.04 (1.98-4.12). We also found a haplotype containing rs1143634- T and rs3917356- T was associated with higher DN risk.
conclusionswe found that the rs16944- G and rs3917356- T allele, interaction between rs16944 and smoking, haplotype containing rs1143634- T and rs3917356- T were all associated with increased DN risk.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.